Home/Filings/4/0000886163-21-000091
4//SEC Filing

Gray Nancy Ryan 4

Accession 0000886163-21-000091

CIK 0000886163other

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 9:24 PM ET

Size

7.1 KB

Accession

0000886163-21-000091

Insider Transaction Report

Form 4
Period: 2021-06-04
Transactions
  • Award

    Common Stock

    2021-06-04+6303,702 total
  • Award

    Non-Qualified Stock Option (right to buy)

    2021-06-04+3,2693,269 total
    Exercise: $115.39Exp: 2031-06-04Common Stock (3,269 underlying)
Footnotes (2)
  • [F1]Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 04, 2021. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.
  • [F2]Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 04, 2021. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

Issuer

LIGAND PHARMACEUTICALS INC

CIK 0000886163

Entity typeother

Related Parties

1
  • filerCIK 0001714949

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 9:24 PM ET
Size
7.1 KB